This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their editorial, Costner and Cockerell¹ mention several skin conditions related to human immunodeficiency virus (HIV) that improve during highly active antiretroviral treatment (HAART). They do not mention, however, the potential adverse dermatological effects of such therapy.

The protease inhibitor indinavir sulfate, for example, may cause alopecia, dry skin, pruritic skin eruptions, and paronychia.^2-3 We observed 2 patients treated with indinavir who developed a vertical lip fissure during the summer. The fissure of the lips probably was related to the dryness of the lips caused by the indinavir. We also observed a patient who lost all the hair on his legs and axillary region during indinavir, stavudine, and lamivudine treatment. His hair started growing again when the indinavir was replaced by nelfinavir. Allergic skin eruptions can be seen with all antivirals but may be particularly severe, leading to a Stevens-Johnson syndrome, with abacavir.⁴

In future cohort studies, not only the . . . [Full Text of this Article]